Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.
• NP283298.RA7HWzgrxDuOp3jAoythw6-r-C-95DXoAlCuzRG0q-CUc130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283298.RA7HWzgrxDuOp3jAoythw6-r-C-95DXoAlCuzRG0q-CUc130_provenance.
• NP375568.RAmhHmmRrJMuXxAGNKG8YzqFh27_pIfHnFoUkkbq14KqY130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375568.RAmhHmmRrJMuXxAGNKG8YzqFh27_pIfHnFoUkkbq14KqY130_provenance.
• NP682442.RAUJEbRCzd-IqoF0XY2XhfGEc7THlG80Gi5_GCOB09js8130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682442.RAUJEbRCzd-IqoF0XY2XhfGEc7THlG80Gi5_GCOB09js8130_provenance.
• assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP279182.RAWeNZ5bLF4zwBSwbFCBXAVfepuZ2go-STfrGTTGRBVU8130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279182.RAWeNZ5bLF4zwBSwbFCBXAVfepuZ2go-STfrGTTGRBVU8130_provenance.
• NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
• NP578885.RAPcMvgsaKY7v7uX30mkTqmw5ZNjz-oxKyF4oJ_Mt1ZV4130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578885.RAPcMvgsaKY7v7uX30mkTqmw5ZNjz-oxKyF4oJ_Mt1ZV4130_provenance.
• NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278874.RAA_jVgqXdqS6BA5yplhlc1wv7v1sDNQJL-UxFOEWJicg130_provenance.
• NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279018.RAtwbfbzVwB1Ekunlq0Axn06mvJhMHs0U8BFm4ci9Elig130_provenance.
• NP278711.RAwEa7hC-ZKYcyrrbR8pQHtH6Srt97Q8vwPA9UVeHy3ks130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278711.RAwEa7hC-ZKYcyrrbR8pQHtH6Srt97Q8vwPA9UVeHy3ks130_provenance.
• NP279331.RAK8yYOtG52qUtNaLTf0yGxG09S4NLDkz_0xmjnWG-620130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279331.RAK8yYOtG52qUtNaLTf0yGxG09S4NLDkz_0xmjnWG-620130_provenance.
• NP418256.RAOKUSa6HiqGeWSrU2PDt12TYJ4skr_CdmLf8jw3CU0bU130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418256.RAOKUSa6HiqGeWSrU2PDt12TYJ4skr_CdmLf8jw3CU0bU130_provenance.
• NP418259.RAFbo0rOKoygf4dyO-OowQ9p5iGfosBJIE8GYU8IRgLac130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418259.RAFbo0rOKoygf4dyO-OowQ9p5iGfosBJIE8GYU8IRgLac130_provenance.
• NP418260.RALnyKdVu-X2Lhr6ALlvJVCUbGE3SaloRO1GFJTq9X-mE130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418260.RALnyKdVu-X2Lhr6ALlvJVCUbGE3SaloRO1GFJTq9X-mE130_provenance.